Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

G Ahlenstiel, MP Martin, X Gao… - The Journal of …, 2008 - Am Soc Clin Investig
G Ahlenstiel, MP Martin, X Gao, M Carrington, B Rehermann
The Journal of clinical investigation, 2008Am Soc Clin Investig
Genetic studies suggest a role for killer cell immunoglobulin-like receptor/HLA (KIR/HLA)
compound genotypes in the outcome of viral infections, but functional data to explain these
epidemiological observations have not been reported. Using an in vitro model of infection
with influenza A virus (IAV), we attribute functional differences in human NK cell activity to
distinct KIR/HLA genotypes. Multicolor flow cytometry revealed that the HLA-C–inhibited NK
cell subset in HLA-C1 homozygous subjects was larger and responded more rapidly in IFN …
Genetic studies suggest a role for killer cell immunoglobulin-like receptor/HLA (KIR/HLA) compound genotypes in the outcome of viral infections, but functional data to explain these epidemiological observations have not been reported. Using an in vitro model of infection with influenza A virus (IAV), we attribute functional differences in human NK cell activity to distinct KIR/HLA genotypes. Multicolor flow cytometry revealed that the HLA-C–inhibited NK cell subset in HLA-C1 homozygous subjects was larger and responded more rapidly in IFN-γ secretion and CD107a degranulation assays than its counterpart in HLA-C2 homozygous subjects. The differential IFN-γ response was also observed at the level of bulk NK cells and was independent of KIR3DL1/HLA-Bw4 interactions. Moreover, the differential response was not caused by differences in NK cell maturation status and phenotype, nor by differences in the type I IFN response of IAV-infected accessory cells between HLA-C1 and HLA-C2 homozygous subjects. These results provide functional evidence for differential NK cell responsiveness depending on KIR/HLA genotype and may provide useful insights into differential innate immune responsiveness to viral infections such as IAV.
The Journal of Clinical Investigation